Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Chemocentryx Inc (NQ: CCXI )

46.26 USD -0.17 (-0.37%)
Official Closing Price Updated: 4:46 PM EDT, Apr 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 846,100
Open 46.44
Bid (Size) 44.93 (1)
Ask (Size) 49.00 (3)
Prev. Close 46.43
Today's Range 44.92 - 47.08
52wk Range 44.28 - 70.29
Shares Outstanding 69,613,267
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ChemoCentryx to Hold First Quarter 2021 Financial Results Conference Call on Thursday, April 29, 2021
From GlobeNewswire News Releases
ChemoCentryx’s Oral PD-L1 inhibitor, CCX559, Featured in Poster Presentation at the 2021 American Association for Cancer Research (AACR) Annual Meeting
From GlobeNewswire News Releases

Performance

YTD
-21.46%
-21.46%
1 Month
-15.52%
-15.52%
3 Month
-26.90%
-26.90%
6 Month
-15.86%
-15.86%
1 Year
-4.87%
-4.87%

More News

Read More
ChemoCentryx to Host Virtual R&D Day on April 14, 2021
From GlobeNewswire News Releases
ChemoCentryx Announces Appointment of Susan M. Kanaya to Board of Directors
From GlobeNewswire News Releases
ChemoCentryx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
From GlobeNewswire News Releases
ChemoCentryx to Present at Two Upcoming Investor Conferences
From GlobeNewswire News Releases
ChemoCentryx Appoints Tausif (‘Tosh’) Butt as Executive Vice President and Chief Operating Officer
From GlobeNewswire News Releases
Peek Under The Hood: RYJ Has 17% Upside
Tags ETFs
From ETF Channel
ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call on Monday, March 1, 2021
From GlobeNewswire News Releases
ChemoCentryx Announces Publication in The New England Journal of Medicine of Results of the Pivotal Phase III ADVOCATE Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis
From GlobeNewswire News Releases
Notable Monday Option Activity: CCXI, KRON, CPLG
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.